Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DIFFERENTIATION THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 308 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lehmann, S; Paul, C; Torma, H
      Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells

      CLINICAL CANCER RESEARCH
    2. Tamagawa, K; Shimizu, K; Ebine, T; Maitani, Y; Fukui, T; Kawai, K; Takahashi, N
      Antitumor efficacy in vitro and in vivo of falconensones, a new type of polyene

      CLINICAL CANCER RESEARCH
    3. Jurcic, JG
      Antibody therapy for residual disease in acute myelogenous leukemia

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    4. Liu, S; Wu, Q; Che, ZM; Su, WJ
      The effect pathway of retinoic acid through regulation of retinoic acid receptor alpha in gastric cancer cells

      WORLD JOURNAL OF GASTROENTEROLOGY
    5. Degos, L; Wang, ZY
      All trans retinoic acid in acute promyelocytic leukemia

      ONCOGENE
    6. Minucci, S; Nervi, C; Lo Coco, F; Pelicci, PG
      Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias?

      ONCOGENE
    7. Visani, G; Buonamici, S; Malagola, M; Isidori, A; Piccaluga, PP; Martinelli, G; Ottaviani, E; Grafone, T; Baccarani, M; Tura, S
      Pulsed ATRA as single therapy restores long-term remission in PML-RAR alpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study

      LEUKEMIA
    8. Asou, N; Adachi, K; Tamura, J; Kanamaru, A; Kageyama, S; Hiraoka, A; Omoto, E; Akiyama, H; Tsubaki, K; Saito, K; Kuriyama, K; Oh, H; Kitano, K; Miyawaki, S; Takeyama, K; Yamada, O; Nishikawa, K; Takahashi, M; Matsuda, S; Ohtake, S; Ohno, R
      Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group(JALSG)

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    9. Takayama, N; Kizaki, M; Hida, T; Kinjo, K; Ikeda, Y
      Novel mutation in the PML/RAR alpha chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoicacid in acute promyelocytic leukemia

      EXPERIMENTAL HEMATOLOGY
    10. Mata-Greenwood, E; Ito, A; Westenburg, H; Cui, BL; Mehta, RG; Kinghorn, AD; Pezzuto, JM
      Discovery of novel inducers of cellular differentiation using HL-60 promyelocytic cells

      ANTICANCER RESEARCH
    11. Deaglio, S; Canella, D; Baj, G; Arnulfo, A; Waxman, S; Malavasi, F
      Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As2O3) on myeloma cells

      LEUKEMIA RESEARCH
    12. Suzuki, H; Imaizumi, M; Sato, A; Yoshinari, M; Rikiishi, T; Endo, M; Takano, T; Shimizu, T; Hatae, Y; Fujimoto, T; Hayashi, Y; Iinuma, K
      Monitoring of minimal residual disease in children with acute promyelocytic leukemia by RT-PCR detecting PML/RAR alpha chimeric gene: A retrospectivestudy of clinical feasibility

      TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
    13. Fenaux, P; Chomienne, C; Degos, L
      All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia

      SEMINARS IN HEMATOLOGY
    14. Almand, B; Clark, JI; Nikitina, E; van Beynen, J; English, NR; Knight, SC; Carbone, DP; Gabrilovich, DI
      Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer

      JOURNAL OF IMMUNOLOGY
    15. Jurcic, JG; Nimer, SD; Scheinberg, DA; DeBlasio, T; Warrell, RP; Miller, WH
      Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia

      BLOOD
    16. Lutz, PG; Houzel-Charavel, A; Moog-Lutz, C; Cayre, YE
      Myeloblastin is an Myb target gene: mechanisms of regulation in myeloid leukemia cells growth-arrested by retinoic acid

      BLOOD
    17. Gianni', M; Kalac, Y; Ponzanelli, I; Rambaldi, A; Terao, M; Garattini, E
      Tyrosine kinase inhibitor ST1571 potentiates the pharmacologic activity ofretinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RAR alpha and PML-RAR alpha

      BLOOD
    18. Maslak, P; Scheinberg, D
      Targeted therapies for the myeloid leukaemias

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    19. Jurcic, JG
      Antibody therapy of acute myelogenous leukemia

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    20. Jurcic, JG; DeBlasio, T; Dumont, L; Yao, TJ; Scheinberg, DA
      Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia

      CLINICAL CANCER RESEARCH
    21. Sumimoto, Y; Maeda, Y; Naiki, Y; Sono, H; Miyatake, J; Sakaguchi, M; Matsuda, M; Kanamaru, A
      Establishment of a myeloid cell line, YM711, characterized by retinoid resistance

      LEUKEMIA & LYMPHOMA
    22. Lentini, A; Vidal-Vanaclocha, F; Facchiano, F; Caraglia, M; Abbruzzese, A; Beninati, S
      Theophylline administration markedly reduces hepatic and pulmonary implantation of B16-F10 melanoma cells in mice

      MELANOMA RESEARCH
    23. Shinjo, K; Takeshita, A; Ohnishi, K; Sakura, T; Miyawaki, S; Hiraoka, A; Takeuchi, M; Tomoyasu, S; Wakita, H; Ata, K; Fukutani, H; Ueda, R; Ohno, R
      Good prognosis of patients with acute promyelocytic leukemia who achieved second complete remission (CR) with a new retinoid, AM80, after relapse from CR induced by all-trans-retinoic acid

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    24. Marchal, JA; Melguizo, C; Prados, J; Aranega, AE; Gomez, JA; Campos, J; Gallo, MA; Espinosa, A; Arena, N; Aranega, A
      Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602)

      JAPANESE JOURNAL OF CANCER RESEARCH
    25. Niles, RM
      Vitamin A and cancer

      NUTRITION
    26. Tong, JH; Fant, X; Benoit, G; Chen, SJ; Chen, Z; Lanotte, M
      Genomic organization of the JEM-1 (BLZF1) gene on human chromosome 1q24: Molecular cloning and analysis of its promoter region

      GENOMICS
    27. Hofmann, WK; Kell, WJ; Fenaux, P; Castaigne, S; Ganser, A; Chomienne, C; Burnett, R; Kowal, C; Hoelzer, D; Burnett, AK
      Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study

      LEUKEMIA
    28. Fenaux, P; Chevret, S; Guerci, A; Fegueux, N; Dombret, H; Thomas, X; Sanz, M; Link, H; Maloisel, F; Gardin, C; Bordessoule, D; Stoppa, AM; Sadoun, A; Muus, P; Wandt, H; Mineur, P; Whittaker, JA; Fey, M; Daniel, MT; Castaigne, S; Degos, L
      Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

      LEUKEMIA
    29. Thomas, X; Dombret, H; Cordonnier, C; Pigneux, A; Gardin, C; Guerci, A; Vekhoff, A; Sadoun, A; Stamatoullas, A; Fegueux, N; Maloisel, F; Cahn, JY; Reman, O; Gratecos, N; Berthou, C; Huguet, F; Kotoucek, P; Travade, P; Buzyn, A; de Revel, T; Vilque, JP; Naccache, P; Chomienne, C; Degos, L; Fenaux, P
      Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

      LEUKEMIA
    30. Grolleau, A; Wietzerbin, J; Beretta, L
      Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NE4-R2

      LEUKEMIA
    31. van der Vliet, HJJ; Roberson, AE; Hogan, MC; Morales, CE; Crader, SC; Letendre, L; Pruthi, RK
      All-trans-retinoic acid-induced myositis: A description of two patients

      AMERICAN JOURNAL OF HEMATOLOGY
    32. Weil, SC
      Minimal residual disease in acute promyelocytic leukemia

      CLINICS IN LABORATORY MEDICINE
    33. Takahashi, N; Shimizu, T; Takeda, K
      Low-dose staurosporine suppresses proliferation and induces neurites in human prostatic cancer TSU-Pr1 cells

      PROSTATE
    34. Cortelezzi, A; Cattaneo, C; Sarina, B; Cristiani, S; Pomati, M; Silvestris, I; Motta, M; Ibatici, A; Gornati, G; Della Volpe, A; Maiolo, AT
      Efficacy of N-acetylcysteine and all-trans retinoic acid in restoring in vitro effective hemopoiesis in myelodysplastic syndromes

      LEUKEMIA RESEARCH
    35. Lehmann, S; Bengtzen, S; Broberg, U; Paul, C
      Effects of retinoids on cell toxicity and apoptosis in leukemic blast cells from patients with non-M3 AML

      LEUKEMIA RESEARCH
    36. Havekes, B; van der Elst, JPS; van der Pluijm, G; Goslings, BM; Morreau, J; Romijn, JA; Smit, JWA
      Beneficial effects of retinoic acid on extracellular matrix degradation and attachment behaviour in follicular thyroid carcinoma cell lines

      JOURNAL OF ENDOCRINOLOGY
    37. Amin, HM; Ergin, M; Denning, MF; Quevedo, ME; Alkan, S
      Characterization of apoptosis induced by protein kinase C inhibitors and its modulation by the caspase pathway in acute promyelocytic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    38. Di Bona, E; Avvisati, G; Castaman, G; Vegna, ML; De Sanctis, V; Rodeghiero, F; Mandelli, F
      Early haemorrhagic morbidity and mortality during remission induction withor without all-trans retinoic acid in acute promyelocytic leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    39. Sainty, D; Liso, V; Cantu-Rajnoldi, A; Head, D; Mozziconacci, MJ; Arnoulet, C; Benattar, L; Fenu, S; Mancini, M; Duchayne, E; Mahon, FX; Gutierrez, N; Birg, F; Biondi, A; Grimwade, D; Lafage-Pochitaloff, M; Hagemeijer, A; Flandrin, G
      A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements

      BLOOD
    40. Tallman, MS; Andersen, JW; Schiffer, CA; Appelbaum, FR; Feusner, JH; Ogden, A; Shepherd, L; Rowe, JM; Francois, C; Larson, RS; Wiernik, PH
      Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome

      BLOOD
    41. Swaminathan, N; Lopez-Berestein, G; Rudikoff, S
      Assessment of all-trans retinoic acid (ATRA) efficacy as a single agent inprimary lymphoid neoplasia

      MEDICAL ONCOLOGY
    42. Kizaki, M; Fukuchi, Y; Ikeda, Y
      A novel retinoic acid-resistant acute promyelocytic leukemia model in vitro and in vivo (review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    43. Yueh, YK; Liew, PPL; Ho, PC; Wu, TS
      Sublingual administration of all-trans-retinoic acid to a comatose patientwith acute promyelocytic leukemia

      ANNALS OF PHARMACOTHERAPY
    44. Mehta, K; Cheema, S
      Retinoid-mediated signaling pathways in CD38 antigen expression in myeloidleukemia cells

      LEUKEMIA & LYMPHOMA
    45. Hofmann, WK; Ganser, A; Seipelt, G; Ottmann, OG; Zander, C; Geissler, G; Hoffmann, K; Hoffken, K; Fischer, JT; Isele, G; Hoelzer, D
      Treatment of patients with low-risk myelodysplastic syndromes using a combination of all-trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor

      ANNALS OF HEMATOLOGY
    46. Shimodaira, S; Kitano, K; Nishizawa, Y; Ichikawa, N; Ishida, F; Kamino, I; Matsui, H; Kiyosawa, K
      Acute myelogenous leukemia with a t(2;17;4)(p13;q21;p16) aberration: Effective treatment with all-trans retinoic acid and granulocyte colony-stimulating factor

      INTERNAL MEDICINE
    47. Hsu, HC; Tsai, WH; Chen, PG; Hsu, ML; Ho, CK; Wang, SY
      In vitro effect of granulocyte-colony stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells

      EUROPEAN JOURNAL OF HAEMATOLOGY
    48. DiGiuseppe, JA; Weng, LJ; Yu, LJ; Yu, KH; Fu, S; Kastan, MB; Samid, D; Gore, SD
      Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis

      LEUKEMIA
    49. Mozziconacci, ML; Liberatore, C; Grignani, F; Sainty, D; Pelicci, PG; Birg, F; Lafage-Pochitaloff, M
      Atypical response to all-trans retinoic acid in a der(5)t(5;17) acute promyelocytic leukemia

      LEUKEMIA
    50. Gianni, M; de The, H
      In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RAR alpha protein and the PML retargeting on PML-nuclear bodies

      LEUKEMIA
    51. Marasca, R; Zucchini, P; Galimberti, S; Leonardi, G; Vaccari, P; Donelli, A; Luppi, M; Petrini, M; Torelli, G
      Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia

      HAEMATOLOGICA
    52. Advani, SH; Nair, R; Bapna, A; Gladstone, B; Kadam, P; Saikia, TK; Parekh, PM; Gopal, R; Nair, CN
      Acute promyelocytic leukemia: All-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone

      AMERICAN JOURNAL OF HEMATOLOGY
    53. JAMES SY; WILLIAMS MA; NEWLAND AC; COLSTON KW
      LEUKEMIA-CELL DIFFERENTIATION - CELLULAR AND MOLECULAR-INTERACTIONS OF RETINOIDS AND VITAMIN-D

      General pharmacology
    54. Galimberti, S; Papineschi, F; Carmignani, A; Testi, R; Fazzi, R; Petrini, M
      Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia

      BONE MARROW TRANSPLANTATION
    55. Tallman, MS
      The thrombophilic state in acute promyelocytic leukemia

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    56. Menell, JS; Cesarman, GM; Jacovina, AT; McLaughlin, MA; Lev, EA; Hajjar, KA
      Annexin II and bleeding in acute promyelocytic leukemia

      NEW ENGLAND JOURNAL OF MEDICINE
    57. Pascual, MJ; Vaquero, M
      Fever, abdominal pain and coma in a 48-year-old patient with acute promyelocytic leukemia during neutropenia following chemotherapy

      MEDICINA CLINICA
    58. Geller, RB; Dix, SP
      Oral chemotherapy agents in the treatment of leukaemia

      DRUGS
    59. Kinjo, K; Kizaki, M; Takayama, N; Michikawa, N; Oda, A; Okamoto, SI; Tahara, T; Kato, T; Miyazaki, H; Ikeda, Y
      Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment

      BRITISH JOURNAL OF HAEMATOLOGY
    60. Fenton, SL; Drayson, MT; Hewison, M; Vickers, E; Brown, G; Bunce, CM
      Clofibric acid: a potential therapeutic agent in AML and MDS

      BRITISH JOURNAL OF HAEMATOLOGY
    61. Marchal, JA; Prados, J; Melguizo, C; Gomez, JA; Campos, J; Gallo, MA; Espinosa, A; Arena, N; Aranega, A
      GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells

      BRITISH JOURNAL OF CANCER
    62. Fenaux, P; Chastang, C; Chevret, S; Sanz, M; Dombret, H; Archimbaud, E; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Maloisel, F; Castaigne, S; Preudhomme, C; Degos, L
      A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia

      BLOOD
    63. Lo Coco, F; Diverio, D; Falini, B; Biondi, A; Nervi, C; Pelicci, PG
      Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia

      BLOOD
    64. Mologni, L; Ponzanelli, I; Bresciani, F; Sardiello, G; Bergamaschi, D; Gianni, M; Reichert, U; Rambaldi, A; Terao, M; Garattini, E
      The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalenecarboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases

      BLOOD
    65. Burnett, AK; Grimwade, D; Solomon, E; Wheatley, K; Goldstone, AH
      Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: Result of the randomized MRC trial

      BLOOD
    66. CONLEY BA; EGORIN MJ; TAIT N; ROSEN DM; SAUSVILLE EA; DOVER G; FRAM RJ; VANECHO DA
      PHASE-I STUDY OF THE ORALLY-ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS

      Clinical cancer research
    67. CONLEY BA; EGORIN MJ; TAIT N; ROSEN DM; SAUSVILLE EA; DOVER G; FRAM RJ; VANECHO DA
      PHASE-I STUDY OF THE ORALLY-ADMINISTERED BUTYRATE PRODRUG, TRIBUTYRIN, IN PATIENTS WITH SOLID TUMORS

      Clinical cancer research
    68. BUDD GT; ADAMSON PC; GUPTA M; HOMAYOUN P; SANDSTROM SK; MURPHY RF; MCLAIN D; TUASON L; PEEREBOOM D; BUKOWSKI RM; GANAPATHI R
      PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/

      Clinical cancer research
    69. BUDD GT; ADAMSON PC; GUPTA M; HOMAYOUN P; SANDSTROM SK; MURPHY RF; MCLAIN D; TUASON L; PEEREBOOM D; BUKOWSKI RM; GANAPATHI R
      PHASE I II TRIAL OF ALL-TRANS-RETINOIC ACID AND TAMOXIFEN IN PATIENTSWITH ADVANCED BREAST-CANCER/

      Clinical cancer research
    70. MOZZICONACCI MJ; LIBERATORE C; BRUNEL V; GRIGNANI F; ARNOULET C; FERRUCCI PF; FERNANDEZ F; SAINTY D; PELICCI PG; BIRG F; LAFAGEPOCHITALOFF M
      IN-VITRO RESPONSE TO ALL-TRANS-RETINOIC ACID OF ACUTE PROMYELOCYTIC LEUKEMIAS WITH NONRECIPROCAL PML RARA OR RARA/PML FUSION GENES/

      Genes, chromosomes & cancer
    71. MATIKAINEN S; LEHTONEN A; SARENEVA T; JULKUNEN I
      REGULATION OF IRF AND STAT GENE-EXPRESSION BY RETINOIC ACID

      Leukemia & lymphoma
    72. Takeuchi, M; Yano, T; Omoto, E; Takahashi, K; Kibata, M; Shudo, K; Harada, M; Ueda, R; Ohno, R
      Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: Clinical experience with a new synthetic retinoid, Am-80

      LEUKEMIA & LYMPHOMA
    73. MARUYAMA K; TSUKADA T; OHKURA N; BANDOH S; HOSONO T; YAMAGUCHI K
      THE NGFI-B SUBFAMILY OF THE NUCLEAR RECEPTOR SUPERFAMILY (REVIEW)

      International journal of oncology
    74. DENIS L; DEBRUYNE F; DEPORRE P; BRUYNSEELS J
      EARLY CLINICAL-EXPERIENCE WITH LIAROZOLE (LIAZAL(TM)) IN PATIENTS WITH PROGRESSIVE PROSTATE-CANCER

      European journal of cancer
    75. ZANCAI P; CARIATI R; RIZZO S; BOIOCCHI M; DOLCETTI R
      RETINOIC ACID-MEDIATED GROWTH ARREST OF EBV-IMMORTALIZED B-LYMPHOCYTES IS ASSOCIATED WITH MULTIPLE CHANGES IN G(1) REGULATORY PROTEINS - P27(KIP1) UP-REGULATION IS A RELEVANT EARLY EVENT

      Oncogene
    76. HOZUMI M
      DIFFERENTIATION THERAPY OF LEUKEMIA - ACHIEVEMENTS, LIMITATIONS AND FUTURE-PROSPECTS

      International journal of hematology
    77. OHNO R
      MULTICENTER COOPERATIVE STUDY-GROUP IN HEMATOLOGY IN JAPAN - THE 10-YEAR HISTORY AND ROLE OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP IN JAPAN

      International journal of hematology
    78. SCHAISON GS
      ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN

      Pediatric hematology and oncology
    79. THOMAS X; FIERE D; ARCHIMBAUD E
      INFLUENCE OF INCREASED BODY-MASS INDEX ON DRUG TOXICITY IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA

      Leukemia
    80. RUSSO D; REGAZZI M; SACCHI S; VISANI C; LAZZARINO M; AVVISATI G; PELICCI PG; DASTOLI G; GRANDI C; IACONA I; CANDONI A; GRATTONI R; GALIENI P; RUPOLI S; LIBERATI AM; MAIOLO AT
      ALL-TRANS-RETINOIC ACID (ATRA) IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA IN THE CHRONIC PHASE

      Leukemia
    81. ASOU N; ADACHI K; TAMURA J; KANAMARU A; KAGEYAMA S; HIRAOKA A; OMOTO E; AKIYAMA H; TSUBAKI K; SAITO K; KURIYAMA K; OH H; KITANO K; MIYAWAKI S; TAKEYAMA K; YAMADA O; NISHIKAWA K; TAKAHASHI M; MATSUDA S; OHTAKE S; SUZUSHIMA H; EMI N; OHNO R
      ANALYSIS OF PROGNOSTIC FACTORS IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTICLEUKEMIA TREATED WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY

      Journal of clinical oncology
    82. ADEDOYIN A; STIFF DD; SMITH DC; ROMKES M; BAHNSON RC; DAY R; HOFACKER J; BRANCH RA; TRUMP DL
      ALL-TRANS-RETINOIC ACID MODULATION OF DRUG-METABOLIZING ENZYME-ACTIVITIES - INVESTIGATION WITH SELECTIVE METABOLIC-DRUG PROBES

      Cancer chemotherapy and pharmacology
    83. Conley, BA; Ramsland, TS; Sentz, DL; Wu, SL; Rosen, DM; Wollman, M; Eiseman, JL
      Antitumor activity, distribution, and metabolism of 13-cis-retinoic acid as a single agent or in combination with tamoxifen in established human MCF-7 xenografts in mice

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    84. GRUSON D; HILBERT G; BOIRON JM; PORTEL L; CONYMAKOUL P; REIFFERS J; GBIKPIBENISSAN G; CARDINAUD JP
      ACUTE RESPIRATORY-DISTRESS SYNDROME DUE TO ALL-TRANS-RETINOIC ACID

      Intensive care medicine
    85. Parthasarathy, R; Mehta, K
      Altered metabolism of all-trans-retinoic acid in liposome-encapsulated form

      CANCER LETTERS
    86. PAYDAS S; SAHIN B; ZORLUDEMIR S; HAZAR B
      ALL-TRANS-RETINOIC ACID AS THE POSSIBLE CAUSE OF NECROTIZING VASCULITIS

      Leukemia research
    87. THOMAS X; ANGLARET B; CAMPOS L; THIEBAUT A; SABIDO O; BAILLY M; ARCHIMBAUD E
      EXPRESSION OF BETA-1-INTEGRINS AND PSEUDO-IMMUNOGLOBULINS ON ACUTE PROMYELOCYTIC LEUKEMIA-CELLS AND ITS MODIFICATIONS DURING IN-VITRO DIFFERENTIATION

      Leukemia research
    88. DEMEDEIROS BC; STRAPASSON E; PASQUINI R; DEMEDEIROS CR
      EFFECT OF ALL-TRANS-RETINOIC ACID ON NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS - RESULTS OF A BRAZILIAN CENTER

      Brazilian journal of medical and biological research
    89. SOIGNET SL; MASLAK P; WANG ZG; JHANWAR S; CALLEJA E; DARDASHTI LJ; CORSO D; DEBLASIO A; GABRILOVE J; SCHEINBERG DA; PANDOLFI PP; WARRELL RP
      COMPLETE REMISSION AFTER TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH ARSENIC TRIOXIDE

      The New England journal of medicine
    90. JONES P; VILLENEUVE GB; FEI CP; DEMARTE J; HAGGARTY AJ; NWE KT; MARTIN DA; LEBUIS AM; FINKELSTEIN JM; GOURSALIN BJ; CHAN TH; LEYLANDJONES BR
      SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2-PYRAZINYLCARBOXAMIDOBENZOATES AND BETA-IONYLIDENEACETAMIDOBENZOATES WITH RETINOIDAL ACTIVITY

      Journal of medicinal chemistry
    91. KAISER A; WOLFBREITINGER M; ALBERS A; DORBIC T; WITTIG B; RIECKEN EO; ROSEWICZ S
      RETINOIC ACID RECEPTOR GAMMA(1) EXPRESSION DETERMINES RETINOID SENSITIVITY IN PANCREATIC-CARCINOMA CELLS

      Gastroenterology
    92. KUBOTA T; KOSHIZUKA K; KOIKE M; USKOKOVIC M; MIYOSHI I; KOEFFLER HP
      19-NOR-26,27-BISHOMO-VITAMIN-D-3 ANALOGS - A UNIQUE CLASS OF POTENT INHIBITORS OF PROLIFERATION OF PROSTATE, BREAST, AND HEMATOPOIETIC CANCER-CELLS

      Cancer research
    93. MILLER WH
      THE EMERGING ROLE OF RETINOIDS AND RETINOIC ACID METABOLISM BLOCKING-AGENTS IN THE TREATMENT OF CANCER

      Cancer
    94. SANTINI V; FERRINI PR
      DIFFERENTIATION THERAPY OF MYELODYSPLASTIC SYNDROMES - FACT OR FICTION

      British Journal of Haematology
    95. MELLIBOVSKY L; DIEZ A; PEREZVILA E; SERRANO S; NACHER M; AUBIA J; SUPERVIA A; RECKER RR
      VITAMIN-D TREATMENT IN MYELODYSPLASTIC SYNDROMES

      British Journal of Haematology
    96. CAMPBELL MJ; DAWSON M; KOEFFLER HP
      GROWTH-INHIBITION OF DU-145 PROSTATE-CANCER CELLS BY A BCL-2 ANTISENSE OLIGONUCLEOTIDE IS ENHANCED BY N-(2-HYDROXYPHENYL)ALL-TRANS RETINAMIDE

      British Journal of Cancer
    97. DING W; LI YP; NOBILE LM; GRILLS G; CARRERA I; PAIETTA E; TALLMAN MS; WIERNIK PH; GALLAGHER RE
      LEUKEMIC CELLULAR RETINOIC ACID RESISTANCE AND MISSENSE MUTATIONS IN THE PML-RAR-ALPHA FUSION GENE AFTER RELAPSE OF ACUTE PROMYELOCYTIC LEUKEMIA FROM TREATMENT WITH ALL-TRANS-RETINOIC ACID AND INTENSIVE CHEMOTHERAPY

      Blood
    98. IMAIZUMI M; SUZUKI H; YOSHINARI M; SATO A; SAITO T; SUGAWARA A; TSUCHIYA S; HATAE Y; FUJIMOTO T; KAKIZUKA A; KONNO T; IINUMA K
      MUTATIONS IN THE E-DOMAIN OF RAR-ALPHA PORTION OF THE PML RAR-ALPHA CHIMERIC GENE MAY CONFER CLINICAL RESISTANCE TO ALL-TRANS-RETINOIC ACIDIN ACUTE PROMYELOCYTIC LEUKEMIA/

      Blood
    99. MULLER S; MILLER WH; DEJEAN A
      TRIVALENT ANTIMONIALS INDUCE DEGRADATION OF THE PML-RAR-ALPHA ONCOPROTEIN AND REORGANIZATION OF THE PROMYELOCYTIC LEUKEMIA NUCLEAR-BODIES IN ACUTE PROMYELOCYTIC LEUKEMIA NB4 CELLS

      Blood
    100. MATSUSHITA H; KIZAKI M; KOBAYASHI H; UENO H; MUTO A; TAKAYAMA N; AWAYA N; KINJO K; HATTORI Y; IKEDA Y
      RESTORATION OF RETINOID SENSITIVITY BY MDR1 RIBOZYMES IN RETINOIC ACID-RESISTANT MYELOID LEUKEMIC-CELLS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 17:44:42